Vulvar and vaginal squamous cell carcinoma · line 1 · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Line of therapy | 1 |
|---|---|
| Track | local_therapy |
| Linked regimen | None |
| ID | IND-VULVAR-VAGINAL-SCC-1L-WLE-SLNB |
|---|---|
| Type | Indication |
| Status | reviewed 2026-07-11 | pending_clinical_signoff |
| Diseases | DIS-VULVAR-VAGINAL-SCC |
| Sources | SRC-GROINSS-V-VANDERZEE-2008 SRC-NCCN-CERVICAL-2025 |
Notes
STUB pending clinical co-lead signoff (CHARTER §6.1; dev-mode-exempted per CHARTER §8.3 — draft content only, NOT published/verified clinical advice). Surgical management is described in prose (stage_requirements / rationale) rather than via the `phases:` + `surgery_id` mechanism (KNOWLEDGE_SCHEMA_SPECIFICATION §17, as demonstrated by IND-MENINGIOMA-1L-RESECTION-RT) because no Surgery/procedure entity for vulvar wide local excision or inguinal sentinel lymph node biopsy exists yet under knowledge_base/hosted/content/procedures/ — authoring one is out of scope for this pass (flagged in the disease-file proposal notes as an open gap). Adjuvant RT for high-risk features (positive/close margins, positive groin nodes) is not modeled as a separate Indication in this pass — open gap.
Used By
Algorithms
ALGO-VULVAR-VAGINAL-SCC-1L- ALGO-VULVAR-VAGINAL-SCC-1L
Disease
DIS-VULVAR-VAGINAL-SCC- Vulvar and vaginal squamous cell carcinoma